Navigation Links
Lemon tea combats cancer

Drinking hot tea with lemon peel could protect the body against skin cancer, US scientists say. The researchers studied 470 people, half of whom had suffered a particular type of skin cancer, and querried them about their tea-drinking habits.//

They found that those who developed skin cancer drank significantly less hot tea.Lemon peel in the tea was found to have more than a 70% reduced risk for skin squamous cell carcinoma (SCC), whereas black tea alone meant a 40% reduction.

These studies have also shown a protective effect of tea against sunburn which may lead to skin cancer Researchers Iman Hakim and Robin Harris, of the University of Arizona, hope the study will help them develop food supplements to help prevent skin cancer.


'"/>




Page: 1

Related medicine news :

1. Lemons Could Give Relief For Patients Suffering From Asthma
2. Cinnamon combats Diabetes
3. Compound of Broccoli combats breast cancer
4. Vitamin B12 can help in detecting cancers
5. Want skin cancer? Please have a cigarette
6. New hope for cancer victims – will vaccine cure the deadly bug
7. Clintons new problem - Is the outgoing American president suffering from skin cancer?
8. Are cancer patients being taken for a ride?
9. Breast cancer treatment to be determined by gene test
10. Ductal lavage may detect early breast cancer
11. Beware of the oral patch! It could be cancer!!!
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Lemon tea combats cancer

(Date:5/16/2008)... Workers, WASHINGTON, May 16 /PRNewswire-USNewswi...cal technicians in the Greater Portland, Oregon an...irst-ever contract as,Teamsters., "The Teamsters ...a,strong contract that gives them job protection a...eral President Jim Hoffa., The workers, both full...
(Date:5/16/2008)... multicenter Phase III clinical trial has found th...AD001) significantly delays cancer progression in ...se had worsened on other treatments. The study wa... at Memorial Sloan-Kettering Cancer Center (MSKCC)...nnual meeting of the American Society for Clinical...
(Date:5/16/2008)...imary care medicine is in a precipitous decline, D...College of Physicians (ACP), today joined with le...o issue a call for comprehensive reforms to attrac... primary care physicians. , During a panel disc...e U.S., Dr. Dale and other panelists spoke about t...
(Date:5/16/2008)...ewswire-USNewswire/- "Huh, what did you,say?" is a...ularly our,children. More than 30 million American...aring loss and the numbers are growing at a dramat...dren have some form of hearing,loss. An effort to ...roblem,is what led Kathlyn Maguire, who has profou...
Breaking Medicine News(10 mins):Health News:Drug fends off kidney cancer progression 2Health News:ACP says major system reforms needed to improve the state of primary care medicine in the US 2Health News:Huh, What Did You Say?: May is 'Better Hearing and Speech Month' 2Health News:Huh, What Did You Say?: May is 'Better Hearing and Speech Month' 3
...out teenagers with eating disorders can do much da...iversity. // The December issue of the journal, Pe...onducted by the researchers from California. More ... surf websites that offer solutions for all kinds ...
...monkeys shows that ,limiting calorie intake may ac... input seems to improve the functioning of importa...nkeys are said to be closely akin to human beings ...hese findings reflect that a reduction in calorie ...
...ation clinic no. 17,faced one of the most deadlies...he last three decades //. 45 women were killed bec...se who died were young addicts below the age of 35...d from severe psychological disorders. Fire insp...
...reaks of the deadly Ebola virus in Africa have bee...hs in nearby forests. //Hotly debated has been whe... or part of a massive die-off. New research publis...st, providing strong evidence that Ebola killed at...
Other Medicine News:Health News:Ebola-Outbreak Kills 5000 Gorillas 2Health News:Ebola-Outbreak Kills 5000 Gorillas 3
(Date:5/16/2008)... Results demonstrating that TYKERB and trastuzumab...nsion of progression-free survival (PFS), -- Comb...side and,outside of the HER2 receptor may create a...ng activity of TYKERB alone despite patients,prev...and chemotherapy, LONDON and PHILADELPHIA, May 16...
(Date:5/16/2008)...Biomarkers -- for Lung Cancer Diagnosis and, Ident...of Unknown Primary ...pes With High Sensitivity and, Specificity and C...er Results of microRNA Signature to Identify Tiss...ng 90% and Specificity of 99%, REHOVOT, Israel an...
(Date:5/16/2008)... Mechanism May Offer Novel Approach to Blood ...ANS, May 16 /- Pharmacopeia... development of novel small,molecule therapeutics,...,Dual Acting Receptor Antagonist (DARA), showed st...in a Phase 2a study in patients with mild to,moder...
(Date:5/15/2008)...icacy for Population Most Affected by Disease -, ...wire-FirstCall/ --,Bayer HealthCare Pharmaceutical...NXX ) today announced that Nexavar(R) (sorafenib) ... 47.3 percent (HR=0.68;,p-value=0.014) in patients...llular carcinoma (HCC), or primary liver cancer ve...
Breaking Medicine Technology:GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 2GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 3GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 4GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 5GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 6GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 7Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) 2Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) 3Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) 4Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) 5Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) 6Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 2Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 3Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 4Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 5Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 6Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 7Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 8Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 2Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 3Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 4Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 5Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 6New Technology Improves the Appearance of Cellulite in a Single Treatment 15215 1New Technology Improves the Appearance of Cellulite in a Single Treatment 15215 2New Technology Improves the Appearance of Cellulite in a Single Treatment 15215 3Democrat Mike Turner Backs Single Payer Healthcare 3B Opponent Feder Undecided 15211 1Democrat Mike Turner Backs Single Payer Healthcare 3B Opponent Feder Undecided 15211 2NCPA Statement on Californias Delay of E Pedigree Implementation 15207 1NCPA Statement on Californias Delay of E Pedigree Implementation 15207 2Large multicenter study suggests new genetic markers for Crohns disease 15204 1Large multicenter study suggests new genetic markers for Crohns disease 15204 2
Shandon Carousel Cassette MicroWriter™ is a carousel-type cassette marking system.
Fully modular system for long-term storage. Available as complete five-drawer system or as individual components.
Store microscope slides with ease, speed, efficiency.
High-quality, epoxy-coated, stackable steel cabinets for the storage of microscope slides, slide filing wallets, processing cassettes, tissue blocks, transparencies and A5 index cards.
Medicine Products: